ASNS: Actelis Networks, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 9.99
Enterprise Value ($M) 9.22
Book Value ($M) 1.06
Book Value / Share 0.18
Price / Book 9.44
NCAV ($M) -0.82
NCAV / Share -0.14
Price / NCAV -12.12

Profitability (mra)
Return on Invested Capital (ROIC) -1.47
Return on Assets (ROA) -0.36
Return on Equity (ROE) -3.78

Liquidity (mrq)
Quick Ratio 0.71
Current Ratio 1.06

Balance Sheet (mrq) ($M)
Current Assets 6.47
Assets 8.36
Liabilities 7.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5.61
Operating Income -7.36
Net Income -6.29
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -6.58
Cash from Investing 3.82
Cash from Financing 3.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Armistice Capital, Llc 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-09-17 41,103 264,336 15.55
2024-09-16 56,285 204,807 27.48
2024-09-13 86,681 576,343 15.04
2024-09-12 138,783 588,925 23.57

(click for more detail)

Similar Companies
APTO – Aptose Biosciences Inc. APVO – Aptevo Therapeutics Inc.
ARTL – Artelo Biosciences, Inc. ASRT – Assertio Holdings, Inc.
ATNF – 180 Life Sciences Corp.


Financial data and stock pages provided by
Fintel.io